Manchester AI Biotech Spin-Out Lands £5m to “Rewrite Chemical Reactions”
The Manchester biotech startup will use the new capital to expand its AI and robotics platform for faster, lower-cost enzyme design.
- On Thursday, biotech company Imperagen announced a £5 million seed round led by PXN Ventures, while appointing Guy Levy-Yurista as CEO to accelerate enzyme engineering development.
- Imperagen replaces traditional trial-and-error enzyme methods with quantum physics-based simulations that predict enzyme behavior across millions of mutations, aiming to accelerate industrial sustainability.
- To refine its models, the company employs robots and automation to generate experimental data in a closed-loop simulation that feeds back into custom AI models.
- With £8.5 million in total funding, Imperagen plans to hire AI specialists, expand lab capabilities, and build commercial functions within two years under Levy-Yurista's leadership.
- Levy-Yurista told TechCrunch the tech makes enzyme development "faster, more reliable, and more commercially accessible," positioning Imperagen alongside competitors like Absci and Biomatter in enzyme engineering.
11 Articles
11 Articles
Biotechnology company Emberagen has announced a £5 million funding round to develop enzyme engineering technologies using quantum physics and artificial intelligence. Emberagen raised £5 million to use quantum physics and AI in enzyme engineering. The biotechnology company Emberagen announced on Thursday that it had raised £5 million ($6.7 million) in a seed funding round led by PXN Ventures, with participation from IQ Capital and Northern Grits…
TechCrunch
RocketNewsImperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.
Imperagen raises £5m to accelerate enzyme engineering
Imperagen, a Manchester-based biotech using AI and quantum physics to engineer better enzymes faster, has closed a £5m seed funding round. Enzymes are biological catalysts used to reduce waste, lower energy usage and decrease overall production costs in everything from pharmaceutical manufacturing and personal care to sustainable chemical production. However, engineering an enzyme for practical application is a challenging and complex process. …
uktechnews.co.uk
manchester.ac.ukUniversity of Manchester techbio spin-out secures £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next gen enzyme engineering
Imperagen, a Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster,... The post University of Manchester techbio spin-out secures £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next gen enzyme engineering appeared first on UK Tech News.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
